Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease.


Journal

NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390

Informations de publication

Date de publication:
31 Aug 2023
Historique:
received: 25 05 2023
accepted: 16 08 2023
medline: 1 9 2023
pubmed: 1 9 2023
entrez: 31 8 2023
Statut: epublish

Résumé

The genetic basis of levodopa-induced-dyskinesia (LiD) is poorly understood, and there have been few well-powered genome-wide studies. We performed a genome-wide survival meta-analyses to study the effect of genetic variation on the development of LiD in five separate longitudinal cohorts, and meta-analysed the results. We included 2784 PD patients, of whom 14.6% developed LiD. We found female sex (HR = 1.35, SE = 0.11, P = 0.007) and younger age at onset (HR = 1.8, SE = 0.14, P = 2 × 10

Identifiants

pubmed: 37652906
doi: 10.1038/s41531-023-00573-2
pii: 10.1038/s41531-023-00573-2
pmc: PMC10471743
doi:

Types de publication

Journal Article

Langues

eng

Pagination

128

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023. Springer Nature Limited.

Références

Bioinformatics. 2016 May 15;32(10):1493-501
pubmed: 26773131
Neurology. 2009 Jan 13;72(2):110-6
pubmed: 18987353
Nat Genet. 2012 Mar 18;44(4):369-75, S1-3
pubmed: 22426310
Mov Disord. 2010 Jul 15;25(9):1177-82
pubmed: 20310028
Pharmacogenet Genomics. 2008 Sep;18(9):815-21
pubmed: 18698234
Nat Genet. 2020 Dec;52(12):1355-1363
pubmed: 33199916
Sci Rep. 2021 Oct 1;11(1):19582
pubmed: 34599261
Neurol Sci. 2021 Oct;42(10):4085-4094
pubmed: 34346015
N Engl J Med. 2019 Jan 24;380(4):315-324
pubmed: 30673543
J Neural Transm (Vienna). 2018 Aug;125(8):1109-1117
pubmed: 29971495
Mov Disord. 2021 Apr;36(4):842-851
pubmed: 33513272
Nucleic Acids Res. 2012 May;40(9):3785-99
pubmed: 22262733
PLoS Comput Biol. 2015 Apr 17;11(4):e1004219
pubmed: 25885710
Nat Genet. 2023 Mar;55(3):377-388
pubmed: 36823318
Neurobiol Dis. 2017 Jun;102:133-139
pubmed: 28315782
Mov Disord. 2012 Jan;27(1):132-5
pubmed: 22083803
N Engl J Med. 2004 Dec 9;351(24):2498-508
pubmed: 15590952
Ann Neurol. 2018 Dec;84(6):797-811
pubmed: 30357892
J Parkinsons Dis. 2015;5(4):947-59
pubmed: 26485428
Mov Disord. 2016 Jun;31(6):915-23
pubmed: 26442452
Br J Psychiatry. 1976 Feb;128:156-65
pubmed: 942576
Neurology. 1999 Oct 22;53(7):1425-30
pubmed: 10534246
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52
pubmed: 2841426
Biol Psychiatry. 2009 Sep 15;66(6):603-13
pubmed: 19520364
Neuro Endocrinol Lett. 2014;35(5):398-404
pubmed: 25275262
Cereb Cortex. 2018 Jan 1;28(1):223-235
pubmed: 27909010
J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):795-808
pubmed: 32576618
Parkinsonism Relat Disord. 2021 Mar;84:52-60
pubmed: 33561612
BMJ Open. 2019 Oct 7;9(10):e029740
pubmed: 31594876
Mov Disord. 2020 Aug;35(8):1346-1356
pubmed: 32557794
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
Genet Epidemiol. 2009 Jan;33(1):79-86
pubmed: 18642345
Am J Hum Genet. 2011 Jan 7;88(1):76-82
pubmed: 21167468
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Neuron. 1999 Oct;24(2):481-9
pubmed: 10571241
Mov Disord. 2021 Aug;36(8):1795-1804
pubmed: 33960523
Science. 1996 Sep 13;273(5281):1516-7
pubmed: 8801636
Mov Disord. 2008 Dec 15;23(16):2398-403
pubmed: 19025759
Ann Clin Transl Neurol. 2020 Sep;7(9):1557-1563
pubmed: 32767721
Brain. 2003 Jun;126(Pt 6):1279-92
pubmed: 12764051
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Genome Med. 2014 Jun 30;6(6):48
pubmed: 25061481
Mol Neurodegener. 2011 May 09;6:30
pubmed: 21554715
Parkinsonism Relat Disord. 2018 Feb;47:39-44
pubmed: 29191473
Bioinformatics. 2022 Jan 3;38(2):536-539
pubmed: 34529038
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Int J Mol Sci. 2022 Aug 10;23(16):
pubmed: 36012187
J R Stat Soc Series B Stat Methodol. 2020 Dec;82(5):1273-1300
pubmed: 37220626
Am J Hum Genet. 2001 Sep;69(3):629-34
pubmed: 11462174
Brain. 2014 Oct;137(Pt 10):2731-42
pubmed: 25034897
Neurodegener Dis. 2014;13(1):24-8
pubmed: 24008922
Prog Neurobiol. 2011 Dec;95(4):629-35
pubmed: 21930184
J Parkinsons Dis. 2012;2(3):189-98
pubmed: 23938226
J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):141-4
pubmed: 18977816
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 19;373(1738):
pubmed: 29203718
Nat Genet. 2021 Sep;53(9):1300-1310
pubmed: 34475573
Parkinsonism Relat Disord. 2010 Sep;16(8):490-7
pubmed: 20598622
Nature. 2003 Dec 18;426(6968):789-96
pubmed: 14685227
Mov Disord. 2022 May;37(5):1016-1027
pubmed: 35106798
Mov Disord. 2013 Jul;28(8):1064-71
pubmed: 23630119
Science. 2019 Nov 29;366(6469):1134-1139
pubmed: 31727856

Auteurs

Alejandro Martinez-Carrasco (A)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK. alejandro.carrasco.20@ucl.ac.uk.
UCL Movement Disorders Centre, University College London, London, UK. alejandro.carrasco.20@ucl.ac.uk.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA. alejandro.carrasco.20@ucl.ac.uk.

Raquel Real (R)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
UCL Movement Disorders Centre, University College London, London, UK.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.

Michael Lawton (M)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Hirotaka Iwaki (H)

Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Data Tecnica International, Glen Echo, MD, USA.

Manuela M X Tan (MMX)

Department of Neurology, Oslo University Hospital, Oslo, Norway.

Lesley Wu (L)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
UCL Movement Disorders Centre, University College London, London, UK.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.

Nigel M Williams (NM)

Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Camille Carroll (C)

Faculty of Health, University of Plymouth, Plymouth, UK.
Translational and Clinical Research Institute, Newcastle University, Newcastle, UK.

Michele T M Hu (MTM)

Nuffield Department of Clinical Neurosciences, Division of Clinical Neurology, University of Oxford, Oxford, UK.
Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.

Donald G Grosset (DG)

School of Neuroscience and Psychology, University of Glasgow, Glasgow, UK.

John Hardy (J)

Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.
Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.
UK Dementia Research Institute, University College London, London, UK.
Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.
National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, London, UK.
Institute for Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China.

Mina Ryten (M)

Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.
Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK.

Tom Foltynie (T)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.

Yoav Ben-Shlomo (Y)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Maryam Shoai (M)

Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA.
Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.
UK Dementia Research Institute, University College London, London, UK.

Huw R Morris (HR)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK. h.morris@ucl.ac.uk.
UCL Movement Disorders Centre, University College London, London, UK. h.morris@ucl.ac.uk.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815, USA. h.morris@ucl.ac.uk.

Classifications MeSH